USPFX
Price
$32.41
Change
+$0.18 (+0.56%)
Updated
Jul 3 closing price
Net Assets
81.45M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

USPFX vs VVIAX

Header iconUSPFX vs VVIAX Comparison
Open Charts USPFX vs VVIAXBanner chart's image
Union Street Partners Value Advisor
Price$32.41
Change+$0.18 (+0.56%)
VolumeN/A
Net Assets81.45M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
USPFX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
USPFX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is USPFX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. USPFX (81.4M). VVIAX pays higher dividends than USPFX: VVIAX (2.18) vs USPFX (0.17). USPFX was incepted earlier than VVIAX: USPFX (9 years) vs VVIAX (25 years). USPFX (1.55) is less costly to investors than VVIAX (0.05). VVIAX is a more actively managed with annual turnover of: 9.00 vs. USPFX (7.18). USPFX has a lower initial minimum investment than VVIAX: USPFX (2500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. USPFX (6.27). USPFX return over 5 years is better than : 86.88 vs. VVIAX (80.13).
USPFXVVIAXUSPFX / VVIAX
Total Expense Ratio1.150.052,300%
Annual Report Gross Expense Ratio1.550.053,100%
Fund Existence9 years25 years-
Gain YTD4.7516.19877%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets81.4M189B0%
Annual Yield % from dividends0.172.188%
Returns for 1 year6.2712.0352%
Returns for 3 years41.9035.17119%
Returns for 5 years86.8880.13108%
Returns for 10 yearsN/A115.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.